ArticleCureus2026
Recurrent Severe Viral-Induced Rhabdomyolysis Associated With Underlying Genetic Variants in a Young Adult: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rhabdomyolysis is a potentially life-threatening syndrome characterized by skeletal muscle breakdown and release of intracellular contents into circulation, which can result in electrolyte abnormalities, acute kidney injury (AKI), and renal failure. Viral infections, particularly influenza, are recognized triggers of rhabdomyolysis; however, recurrent or unusually severe presentations may suggest underlying genetic susceptibility. We report a case of a previously healthy 21-year-old male with a prior history of COVID-19-associated rhabdomyolysis who presented to the emergency department with fever, generalized weakness, myalgia, red urine, and decreased oral intake following influenza A infection. Laboratory evaluation demonstrated severe rhabdomyolysis with creatine kinase (CK) elevation from 512,650 IU/L to a peak of over 1,000,000 IU/L, complicated by pigment-induced AKI requiring temporary hemodialysis. Extensive autoimmune, metabolic, and neuromuscular evaluation was unremarkable. Subsequent genetic testing identified a heterozygous pathogenic STAC3 variant and variants of uncertain significance in SCN4A, PLEC, and MYH7, raising suspicion for an underlying inherited predisposition to recurrent viral-induced muscle injury. This case highlights the importance of considering genetic susceptibility in patients with recurrent or severe viral-induced rhabdomyolysis, particularly in the setting of extreme CK elevation and recurrent episodes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.